Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lornoxicam in clinical practice.

H Berry1, S Ollier

  • 1Department of Rheumatology, King's College Hospital, London, U.K.

Postgraduate Medical Journal
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automatic analysis of negation cues and scopes for medical texts in French using language models.

Computers in biology and medicine·2025
Same author

Systematic assessment of the reliability of quantitative PCR assays targeting IS900 for the detection of Mycobacterium avium ssp. paratuberculosis presence in animal and environmental samples.

Journal of dairy science·2024
Same author

A systematic review of community pharmacy interventions to improve peri- and post-menopausal health.

Post reproductive health·2024
Same author

Corrigendum to "Effect of inhibiting the lactogenic signal at calving on milk production and metabolic and immune perturbations in dairy cows" (J. Dairy Sci. 100:5782-5791).

Journal of dairy science·2018
Same author

Effects of photoperiod modulation and melatonin feeding around drying-off on bovine mammary gland involution.

Journal of dairy science·2017
Same author

Innovative dairy cow management to improve resistance to metabolic and infectious diseases during the transition period.

Research in veterinary science·2017

Lornoxicam effectively treats osteoarthritis and rheumatoid arthritis. The optimal dosage for osteoarthritis is confirmed to be 12 mg daily, offering a useful therapeutic option.

Area of Science:

  • Pharmacology
  • Rheumatology
  • Clinical Medicine

Background:

  • Osteoarthritis and rheumatoid arthritis are prevalent inflammatory joint conditions.
  • Effective pain management and disease modification are crucial for improving patient outcomes.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for symptom relief.

Purpose of the Study:

  • To evaluate the efficacy of lornoxicam in treating osteoarthritis.
  • To determine the optimal daily dosage of lornoxicam for osteoarthritis management.
  • To assess the overall utility of lornoxicam in treating inflammatory arthropathies.

Main Methods:

  • Review and synthesis of data from three distinct clinical studies.
  • Analysis of treatment outcomes in patients with osteoarthritis and rheumatoid arthritis.

Related Experiment Videos

  • Dose-ranging assessments to identify the most effective lornoxicam regimen.

    • Main Results:

    • Lornoxicam demonstrated significant efficacy in the treatment of osteoarthritis.
    • The ideal daily dosage for osteoarthritis was identified as 12 mg.
    • The drug showed promise as a beneficial treatment for rheumatoid arthritis as well.

    Conclusions:

    • Lornoxicam is an effective therapeutic agent for osteoarthritis.
    • A daily dose of 12 mg is recommended for optimal lornoxicam efficacy in osteoarthritis.
    • Current data suggest lornoxicam is a valuable option for managing both osteoarthritis and rheumatoid arthritis.